• Users Online: 352
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2020  |  Volume : 9  |  Issue : 1  |  Page : 51-54

A rare presentation of chronic myeloid leukemia blast crisis


1 Medgenome Labs LTD, Fortis Hospitals, Bengaluru, Karnataka, India
2 Department of Flow Cytometry, Fortis Hospitals, Bengaluru, Karnataka, India

Correspondence Address:
Dr. P S Shruthi
Medgenome Labs Ltd., Bengaluru, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijh.ijh_16_19

Rights and Permissions

Chronic myeloid leukemia (CML), as the name suggests, is a chronic disorder in which granulocytes undergo dysregulated production and uncontrolled proliferation. Majority of CML patients present during the chronic phase (CP) of the disease. The interval from CP to onset of blastic transformation and acute leukemia can vary from days to several years. The biological basis of blast phase is poorly understood. Most common blast crisis is myeloid type and less frequently lymphoid or promyelocytic. The transformation of CML to promyelocytic blast crisis is a rare form. These findings suggest that BCR-ABL1 gene arises from leukemic stem cell (LSC) which is still not committed to myeloid or lymphoid differentiation. The blastic clone may originate either at the multipotent LSC or at committed leukemia progenitor cell. Here, we report a case of promyelocytic blast crisis with t(15;17) in addition to t(9;22).


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed267    
    Printed17    
    Emailed0    
    PDF Downloaded61    
    Comments [Add]    

Recommend this journal